NDC properties for "SMX 400 MG / TMP 80 MG Oral Tablet" (RxCUI 198334)
About this data
The tables show NDC propoerties for SMX 400 MG / TMP 80 MG Oral Tablet with the RxCUI 198334
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for SMX 400 MG / TMP 80 MG Oral Tablet (RxCUI 198334)
| ANDA | ANDA071017 |
|---|---|
| ANDA | ANDA076817 |
| ANDA | ANDA076899 |
| ANDA | ANDA078060 |
| ANDA | ANDA090624 |
| MMSL_CODE | BD3240 |
| MMSL_CODE | CD3240 |
| RxCUI | 198334 |
| SNOMEDCT | 324357002 |
| SPL_SET_ID | 1b5de94f-973a-4b5a-91d7-45e05be78650 |
| SPL_SET_ID | 284b5dac-2b8d-46bf-95fe-80ce03fa178a |
| SPL_SET_ID | 29df8839-3dfa-0b2b-c5a3-906db6997b3b |
| SPL_SET_ID | 2d510d20-dd62-4b7a-b925-a3b71256a049 |
| SPL_SET_ID | 3233c54d-484d-4550-b172-db8af47d1b7f |
| SPL_SET_ID | 32e2b197-e171-444d-86ca-198d4c84d7a5 |
| SPL_SET_ID | 3edca473-8fdc-462a-b378-6c3279503a70 |
| SPL_SET_ID | 407fe0e4-f1e9-4876-e054-00144ff88e88 |
| SPL_SET_ID | 4833319a-a7b3-4bf4-bec4-6531b43182d4 |
| SPL_SET_ID | 5c51042b-892c-f688-e053-2a91aa0a44d9 |
| SPL_SET_ID | 7f25bff3-0e86-4bec-b293-54b68347867f |
| SPL_SET_ID | 9f130443-c8e7-9122-8f27-f72f07f3f29e |
| SPL_SET_ID | bd3161fe-23d7-458a-86a4-fb958d9c94d3 |
| SPL_SET_ID | ce44959b-4bfe-4ba9-9fc2-7f9d4663d542 |
| SPL_SET_ID | e1a3748d-ca73-4e56-95ad-d25189cc346e |
| SPL_SET_ID | e4a7572f-b372-40eb-963f-919ac100b7a8 |
| SPL_SET_ID | f0e73842-6002-43c2-97fc-0cadc1bf6346 |
| SPL_SET_ID | fb9d264a-0536-4517-84f1-2ea2f57658fe |
| VUID | 4001954 |
| VUID | 4008223 |
| VUID | 4013974 |
| Prescribable Synonym | sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet |
| RXNAV_STR | sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet |
| RxNorm Name | sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet |
| RxNorm Synonym | SMX 400 MG / TMP 80 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 198334) |
NDC Properties
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 00093008801
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-01 |
| NDC Item | 00093008801 |
| Packaging | 100 TABLET in 1 BOTTLE (0093-0088-01) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00093008805
| NDC 9 | 0093-0088 |
|---|---|
| NDC 10 | 0093-0088-05 |
| NDC Item | 00093008805 |
| Packaging | 500 TABLET in 1 BOTTLE (0093-0088-05) |
| ANDA | ANDA070030 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 120175 |
| Imprint code | 93;088 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1990-09-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0093-0088 |
NDC Item 00527144201
| NDC 10 | UNKNOWN |
|---|---|
| NDC Item | 00527144201 |
| Related queries | Properties for NDC 9 |
NDC Item 00603578021
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-21 |
| NDC Item | 00603578021 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (0603-5780-21) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 00603578028
| NDC 9 | 0603-5780 |
|---|---|
| NDC 10 | 0603-5780-28 |
| NDC Item | 00603578028 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (0603-5780-28) |
| ANDA | ANDA078060 |
| COLORTEXT | WHITE(to off white) |
| Color | C48325 __ |
| FDA SPL set id | 225134 |
| Imprint code | 5897;V |
| Labeler | Endo USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 12 mm |
| Related queries | Properties for NDC 9 0603-5780 |
NDC Item 33261039600
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-00 |
| NDC Item | 33261039600 |
| Packaging | 100 TABLET in 1 BOTTLE (33261-396-00) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 33261039630
| NDC 9 | 33261-396 |
|---|---|
| NDC 10 | 33261-396-30 |
| NDC Item | 33261039630 |
| Packaging | 30 TABLET in 1 BOTTLE (33261-396-30) |
| ANDA | ANDA076899 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 79225 |
| Imprint code | IP;271 |
| Labeler | Aidarex Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 33261-396 |
NDC Item 42291075801
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-01 |
| NDC Item | 42291075801 |
| Packaging | 100 TABLET in 1 BOTTLE (42291-758-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 42291075850
| NDC 9 | 42291-758 |
|---|---|
| NDC 10 | 42291-758-50 |
| NDC Item | 42291075850 |
| Packaging | 500 TABLET in 1 BOTTLE (42291-758-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 762247 |
| Imprint code | IP;271 |
| Labeler | AvKARE |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2015-08-05 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 42291-758 |
NDC Item 49999050320
| NDC 9 | 49999-503 |
|---|---|
| NDC 10 | 49999-503-20 |
| NDC Item | 49999050320 |
| Related queries | Properties for NDC 9 49999-503 |
NDC Item 50268072811
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-11 |
| NDC Item | 50268072811 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 50268072815
| NDC 9 | 50268-728 |
|---|---|
| NDC 10 | 50268-728-15 |
| NDC Item | 50268072815 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-728-15) / 1 TABLET in 1 BLISTER PACK (50268-728-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 761104 |
| Imprint code | H;48 |
| Labeler | AvPAK |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-09-23 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 50268-728 |
NDC Item 53489014501
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-01 |
| NDC Item | 53489014501 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (53489-145-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53489014505
| NDC 9 | 53489-145 |
|---|---|
| NDC 10 | 53489-145-05 |
| NDC Item | 53489014505 |
| Packaging | 500 TABLET in 1 BOTTLE, PLASTIC (53489-145-05) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 800305 |
| Imprint code | MP;81 |
| Labeler | Sun Pharmaceutical Industries, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 53489-145 |
NDC Item 53746027101
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-01 |
| NDC Item | 53746027101 |
| Packaging | 100 TABLET in 1 BOTTLE (53746-271-01) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027105
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-05 |
| NDC Item | 53746027105 |
| Packaging | 500 TABLET in 1 BOTTLE (53746-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027110
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-10 |
| NDC Item | 53746027110 |
| Packaging | 1000 TABLET in 1 BOTTLE (53746-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 53746027150
| NDC 9 | 53746-271 |
|---|---|
| NDC 10 | 53746-271-50 |
| NDC Item | 53746027150 |
| Packaging | 50 TABLET in 1 BOTTLE (53746-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 810836 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 53746-271 |
NDC Item 55289045720
| NDC 9 | 55289-457 |
|---|---|
| NDC 10 | 55289-457-20 |
| NDC Item | 55289045720 |
| Packaging | 20 TABLET in 1 BOTTLE, PLASTIC (55289-457-20) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 626473 |
| Imprint code | IP;271 |
| Labeler | PD-Rx Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48345 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 55289-457 |
NDC Item 57237023201
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-01 |
| NDC Item | 57237023201 |
| Packaging | 100 TABLET in 1 BOTTLE (57237-232-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 57237023205
| NDC 9 | 57237-232 |
|---|---|
| NDC 10 | 57237-232-05 |
| NDC Item | 57237023205 |
| Packaging | 500 TABLET in 1 BOTTLE (57237-232-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 808929 |
| Imprint code | H;48 |
| Labeler | Rising Pharma Holdings, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 57237-232 |
NDC Item 60429025801
| NDC 9 | 60429-258 |
|---|---|
| NDC 10 | 60429-258-01 |
| NDC Item | 60429025801 |
| Packaging | 100 TABLET in 1 BOTTLE, PLASTIC (60429-258-01) |
| ANDA | ANDA071017 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 572932 |
| Imprint code | MP;81 |
| Labeler | Golden State Medical Supply, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1986-08-25 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60429-258 |
NDC Item 60687054211
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-11 |
| NDC Item | 60687054211 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687054221
| NDC 9 | 60687-542 |
|---|---|
| NDC 10 | 60687-542-21 |
| NDC Item | 60687054221 |
| Packaging | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-542-21) / 1 TABLET in 1 BLISTER PACK (60687-542-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 625009 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2023-08-31 |
| Marketing effective time low | 2020-01-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 60687-542 |
NDC Item 60687060311
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-11 |
| NDC Item | 60687060311 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 60687060365
| NDC 9 | 60687-603 |
|---|---|
| NDC 10 | 60687-603-65 |
| NDC Item | 60687060365 |
| Packaging | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-603-65) / 1 TABLET in 1 BLISTER PACK (60687-603-11) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 831786 |
| Imprint code | H;48 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2026-03-31 |
| Marketing effective time low | 2022-02-02 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 60687-603 |
NDC Item 61971011501
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-01 |
| NDC Item | 61971011501 |
| Packaging | 100 TABLET in 1 BOTTLE (61971-115-01) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 61971011505
| NDC 9 | 61971-115 |
|---|---|
| NDC 10 | 61971-115-05 |
| NDC Item | 61971011505 |
| Packaging | 500 TABLET in 1 BOTTLE (61971-115-05) |
| ANDA | ANDA076817 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 447833 |
| Imprint code | VISTA115 |
| Labeler | Vista Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2006-06-06 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 61971-115 |
NDC Item 62135089718
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-18 |
| NDC Item | 62135089718 |
| Packaging | 180 TABLET in 1 BOTTLE (62135-897-18) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 62135089790
| NDC 9 | 62135-897 |
|---|---|
| NDC 10 | 62135-897-90 |
| NDC Item | 62135089790 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-897-90) |
| ANDA | ANDA078060 |
| COLORTEXT | white(white to off white) |
| Color | C48325 __ |
| FDA SPL set id | 768757 |
| Imprint code | CE;103 |
| Labeler | Chartwell RX, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2007-01-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62135-897 |
NDC Item 65162027105
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-05 |
| NDC Item | 65162027105 |
| Packaging | 50 TABLET in 1 BOTTLE (65162-271-05) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027110
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-10 |
| NDC Item | 65162027110 |
| Packaging | 100 TABLET in 1 BOTTLE (65162-271-10) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027111
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-11 |
| NDC Item | 65162027111 |
| Packaging | 1000 TABLET in 1 BOTTLE (65162-271-11) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65162027150
| NDC 9 | 65162-271 |
|---|---|
| NDC 10 | 65162-271-50 |
| NDC Item | 65162027150 |
| Packaging | 500 TABLET in 1 BOTTLE (65162-271-50) |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 833044 |
| Imprint code | IP;271 |
| Labeler | Amneal Pharmaceuticals LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 65162-271 |
NDC Item 65862041901
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-01 |
| NDC Item | 65862041901 |
| Packaging | 100 TABLET in 1 BOTTLE (65862-419-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041905
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-05 |
| NDC Item | 65862041905 |
| Packaging | 500 TABLET in 1 BOTTLE (65862-419-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041920
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-20 |
| NDC Item | 65862041920 |
| Packaging | 20 TABLET in 1 BOTTLE (65862-419-20) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 65862041999
| NDC 9 | 65862-419 |
|---|---|
| NDC 10 | 65862-419-99 |
| NDC Item | 65862041999 |
| Packaging | 1000 TABLET in 1 BOTTLE (65862-419-99) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 799337 |
| Imprint code | H;48 |
| Labeler | Aurobindo Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 65862-419 |
NDC Item 68084074795
| NDC 9 | 68084-747 |
|---|---|
| NDC 10 | 68084-747-95 |
| NDC Item | 68084074795 |
| Packaging | 1 in 1 BLISTER PACK |
| ANDA | ANDA076899 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 486635 |
| Imprint code | IP;271 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2021-08-31 |
| Marketing effective time low | 2014-05-30 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 13 mm |
| Related queries | Properties for NDC 9 68084-747 |
NDC Item 69043001001
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-01 |
| NDC Item | 69043001001 |
| Packaging | 100 TABLET in 1 BOTTLE (69043-010-01) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 69043001005
| NDC 9 | 69043-010 |
|---|---|
| NDC 10 | 69043-010-05 |
| NDC Item | 69043001005 |
| Packaging | 500 TABLET in 1 BOTTLE (69043-010-05) |
| ANDA | ANDA090624 |
| COLORTEXT | WHITE(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 807328 |
| Imprint code | H;48 |
| Labeler | Cronus Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2010-02-16 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 69043-010 |
NDC Item 70518345400
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-0 |
| NDC Item | 70518345400 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-0) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345401
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-1 |
| NDC Item | 70518345401 |
| Packaging | 14 TABLET in 1 BOTTLE, PLASTIC (70518-3454-1) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | RemedyRepack, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |
NDC Item 70518345402
| NDC 9 | 70518-3454 |
|---|---|
| NDC 10 | 70518-3454-2 |
| NDC Item | 70518345402 |
| Packaging | 6 TABLET in 1 BOTTLE, PLASTIC (70518-3454-2) |
| ANDA | ANDA090624 |
| COLORTEXT | white(White to Off-white) |
| Color | C48325 __ |
| FDA SPL set id | 820985 |
| Imprint code | H;48 |
| Labeler | REMEDYREPACK INC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-07-18 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | Beveled Edge |
| Shape | C48348 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 70518-3454 |